- Press Releases
- Notices
Press Releases To List
-
- Jan.28.2022R & D
- Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination with Azacitidine
-
- Jan.25.2022R & D
- Opdivo® Intravenous Infusion Approved for the First-line Treatment of Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer in Combination with Bevacizumab and Chemotherapy in Taiwan
-
- Jan.17.2022Licensing
- Ono Expands Drug Discovery Collaboration with Neurimmune AG in the Field of Neurodegenerative Diseases
About
We Want to Deliver New Drugs
to the World with a Wish.
For more than 300 years since its foundation in 1717, working for people’s health.
Diseases still unconquered. Patients' wishes still unfulfilled.
ONO, with a wish to meet these medical needs, devotes all its efforts to drug discovery.
